Skip to main navigation Skip to search Skip to main content

Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia

  • Claudie Bosc
  • , Estelle Saland
  • , Aurélie Bousard
  • , Noémie Gadaud
  • , Marie Sabatier
  • , Guillaume Cognet
  • , Thomas Farge
  • , Emeline Boet
  • , Mathilde Gotanègre
  • , Nesrine Aroua
  • , Pierre Luc Mouchel
  • , Nathaniel Polley
  • , Clément Larrue
  • , Eléonore Kaphan
  • , Muriel Picard
  • , Ambrine Sahal
  • , Latifa Jarrou
  • , Marie Tosolini
  • , Florian Rambow
  • , Florence Cabon
    • Nathalie Nicot, Laura Poillet-Perez, Yujue Wang, Xiaoyang Su, Quentin Fovez, Jérôme Kluza, Rafael José Argüello, Céline Mazzotti, Hervé Avet-Loiseau, François Vergez, Jérôme Tamburini, Jean Jacques Fournié, Ing S. Tiong, Andrew H. Wei, Tony Kaoma, Jean Christophe Marine, Christian Récher, Lucille Stuani, Carine Joffre, Jean Emmanuel Sarry*
*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

94 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology